Contact the Editorial Desk

Correspondence

Auroa Peptides is glad to hear about the research record: a citation quoted inaccurately, a regulatory reference that has since changed, or a peer-reviewed study on GHK-Cu, BPC-157, TB-500, or the GLOW combination that merits a place in the references list. Corrections that sharpen the review are the most useful mail that arrives, and each is read with care.

The notes easiest to act on are specific: they name the page, the exact passage at issue, and a supporting DOI or PubMed ID. That lets a proposed change be checked against its source directly.

Editorial mailbox: editors@auroapeptides.com

Outside the bench's reach

A few things sit outside what the site can take on — flagged so no message waits on an answer it will never get. Auroa Peptides reviews literature; it is not a clinic and not a vendor, so it cannot:

• Advise on, endorse, or comment on human use of any compound covered here.
• Name a dose, schedule, or route for any individual.
• Diagnose a condition or judge whether a finding fits a particular person.
• Sell, source, recommend, or help you locate any compound from any supplier or clinic.
• Field anti-doping questions from athletes about the GLOW blend or its constituents, two of whose three peptides are prohibited by WADA.

Anyone seeking medical or cosmetic guidance should consult a licensed clinician in their own jurisdiction. The mailbox is checked intermittently; replies are not guaranteed.